Long non-coding RNA FLJ22763 is involved in the progression and prognosis of gastric cancer

Abstract Long noncoding RNAs (lncRNAs) play important roles in carcinogenesis. It is necessary to uncover the detailed pattern of comprehensive lncRNA expression in the genome during the development of gastric cancer (GC). We implemented lncRNA microarray analysis in 5 paired GC tissues to detect the lncRNA expression profile. Moreover, we set out to explore the biological function, clinical application and molecular basis of the aberrant lncRNA in GC. In addition, we used the high-throughput microarray to identify the target gene of the aberrant lncRNA. We found that FLJ22763, a novel lncRNA, had significantly lower expression in GC tissues. Decreased expression of FLJ22763 was positively correlated with a lower-level histological grade and the depth of invasion. The ectopic expression of lncRNA FLJ22763 significantly suppressed the biological malignant behavior of GC cells and inhibited xenograft tumor growth (both P P  = 0.003). Furthermore, we found that FLJ22763 was negatively associated with ACLY , regulating the mRNA and protein levels of ACLY . Our findings suggested that FLJ22763 may act as a suppressor gene to regulate the expression of ACLY , and its down-expression may be an independent prognostic factor in patients with GC.